Insider Trading (Form 4)
NASDAQ
DOX
Amdocs LTDMatthew E. Smith, Secretary and Head of Investor Relations at Amdocs Ltd, disposed of 464 shares at a price of $62.51 per share.
NASDAQ
DOX
Amdocs LTDAmdocs CEO Shimie Hortig was granted 84,483 restricted ordinary shares as part of a time-based compensation package.
Schedule 13G - Passive Investments
See all →NASDAQ
DOX
Amdocs LTDFMR LLC, through its affiliates, has disclosed beneficial ownership of 10,032,312.93 shares, representing 9.4% of Amdocs Limited's common stock as of June 30, 2026.
NASDAQ
DOX
Amdocs LTDPzena Investment Management has increased its beneficial ownership of Amdocs Ltd. common stock to 13.2%, holding over 14.2 million shares.
NASDAQ
DOX
Amdocs LTDFMR LLC and Abigail P. Johnson have reported beneficial ownership of 11.2% of Amdocs Limited's common stock as of December 31, 2025.
NASDAQ
DOX
Amdocs LTDPzena Investment Management LLC has disclosed an 11.3% beneficial ownership stake in Amdocs Ltd, holding over 12 million shares as of December 31, 2025.
NASDAQ
DOX
Amdocs LTDJanus Henderson Group plc has filed an Amendment No. 11 to its Schedule 13G, reporting a 2.3% beneficial ownership stake in Amdocs Limited as of September 30, 2025.
NASDAQ
DOX
Amdocs LTDJanus Henderson Group plc has filed an amended Schedule 13G, reporting a 5.2% beneficial ownership stake in Amdocs Limited's Ordinary Shares.